web analytics
July 24, 2016 / 18 Tammuz, 5776

Posts Tagged ‘medical’

Tiberias Medical First Response Team Now Trained in Firefighting Too

Sunday, July 3rd, 2016

17 employees of the The Baruch Padeh Medical Center, Poriya, near Tiberias in northern Israel have graduated a firefighting course which has now turned them into a well rounded first response team serving the Lake Kinneret area.

The first respondents were picked from a variety of hospital sectors to undergo special training at the Tiberias fire station. They received training in putting out fires, recognizing and handling dangerous materials, and scanning for and evacuating victims. The group passed a test at the end of the training.

According to Alex Shalmanzon, the Safety Officer at the Medical Center, the special crew will enhance the hospital’s ability to offer first response at a fire event and be able to effect an organized handing over control of the scene once the firefighters arrive on the scene.

Administrative Director Shimon Sabah praised the hospital employees who volunt

eered to undergo the special training, to boost the area’s readiness in times of an emergency.

JNi.Media

Weizmann Institute Teams with Pfizer

Tuesday, June 7th, 2016

The Weizmann Institute in Rehovot and its commercial arm, the Yeda Research and Development company has announced a multi-year deal with Pfizer Pharmaceuticals’ Global  Research division, to explore areas of research that may not be as often addressed in the United States.

The agreement, made public on Monday (June 6), involves collaboration at the newly-established National Drug Discovery Institute (DDI) – located at the Weizmann Institute – in the Nancy and Steven Grand Israel National Center for Personalized Medicine (G-INCPM).

The center will work on projects of mutual interest, in particular those that might address unmet medical needs.

“This is an exciting partnership for Pfizer,” said Mikael Dolsten, President of Pfizer Global Research.

“We have interacted with the Weizmann Institute for many years and have confidence in their scientific vision and expertise. We anticipate that this arrangement could potentially result in meaningful discoveries in the coming years,” he added.

For projects that appear to have further potential, Pfizer and Yeda said they would discuss research and development agreements.

Hana Levi Julian

Anxious Callers Can Now Track Israeli MDA Ambulances Via GPS

Monday, June 6th, 2016

Ever wonder how long it will take till the ambulance arrives?

Magen David Adom Israel has entered the 21st century (CE) with a new GPS service that allows anxiously waiting families and others to track the route of their ambulances up to arrival.

The new service began June 1, allowing a caller to see where the ambulance is via a link that is sent to the caller’s mobile phone from the dispatch center.

A text message containing the hyperlink is sent by the dispatch computer system to the caller’s phone, connecting the caller with a map that helps track the location of the assigned vehicle.

Hana Levi Julian

Medical Update on Soldier Wounded in Ramming Attack

Friday, May 6th, 2016

The soldier who was wounded in Tuesday’s ramming/terror attack near Dolev continues to be in serious condition.

He is being treated at Sheba hospital in Tel Hashomer. He is still unconscious and on a respirator. His life is still in danger.

Prayers can be said for Matan ben Sara.

Jewish Press News Briefs

Israeli Scientists Find Protein in Blood to ID Alzheimer’s Disease

Tuesday, February 9th, 2016

Researchers at Tel Aviv University, Technion, Rambam Medical Center and Harvard University discovered a new biomarker to identify cognitive aging and Alzheimer’s disease.

The new study, published in the Journal of Alzheimer’s Disease, found that levels of “activity-dependent neuroprotective protein” (ADNP) can be easily monitored in routine blood tests. Moreover, ADNP levels in blood tests correlate with higher IQ in healthy older adults.

The research was led by Prof. Illana Gozes, the incumbent of the Lily and Avraham Gildor Chair for the Investigation of Growth Factors. She is also former director of the Adams Super Center for Brain Studies at TAU’s Sackler Faculty of Medicine and a member of TAU’s Sagol School of Neuroscience. It was also spearheaded by Dr. Gad Marshall, Dr. Aaron Schultz, and Prof. Reisa Sperling of Harvard University, and Prof. Judith Aharon-Peretz of Rambam Medical Center – The Technion Institute of Technology. TAU PhD student Anna Malishkevich also participated in working with the team.

Investigators analyzed blood samples taken from 42 healthy adults, MCI (mild cognitive impairment) patients and Alzheimer’s disease patients at Rambam Medical Center in Israel. After comparing the DNP expression in the blood samples, the researchers prepared plasma samples and once again compared the protein levels.

Significant increases in ADNP RNA were seen in patients ranging from mild cognitive impairment (MCI) to Alzheimer’s disease. ADNP levels tested in plasma and serum samples, as well as white blood cell RNA levels, distinguished between cognitively normal elderly, MCI and Alzheimer’s disease participants.

“This study has provided the basis to detect this biomarker in routine, non-invasive blood tests, and it is known that early intervention is invaluable to Alzheimer’s patients,” Gozes said.

“We are now planning to take these preliminary findings forward into clinical trials — to create a pre-Alzheimer’s test that will help to tailor potential preventative treatments. We have found a clear connection between ADNP levels in the blood and amyloid plaques in the brain,” she said.

The researchers are currently exploring larger clinical trials to better determine the ability of ADNP to predict cognitive decline and disease progression.

Hana Levi Julian

Litzman Pressures Reluctant Hospitals to Shorten Wait for MRI Scans

Tuesday, December 22nd, 2015

At least two medical centers in Israel are locked in a power struggle with the Health Ministry over funding support for MRI procedures.

The number of MRI exams carried out in the afternoon and evening hours was seriously reduced beginning December 1 by the Clalit HMO at Beilinson Medical Center in Petach Tikvah and Be’er Sheva’s Sorokah Medical Center, Galei Tzahal Army Radio reported Tuesday.

This, despite a reform announced by Health Minister Ya’acov Litzman that was supposed to sharply cut the long wait for such procedures.

Because the MRI machine-hours have been slashed in the afternoon and evening hours at the two hospitals, many clinics have been unable to schedule patients for MRI exams as well.

Officials blamed a lack of state funding was responsible for the cut in services.

“Unfortunately we ran out of funds to operate the second shift, so we were forced to reduce our services by 30 percent,” said a spokesperson for Beilinson Medical Center.

“Operating the MRI in afternoon and evening hours is only possible with funding from the state,” said Soroka Medical Center. “The budget just could not stretch far enough, and therefore our services were reduced.”

The Ministry of Health has responded that the “availability and quality of services in the health basket are dependent upon the financial situation of the specific health fund; the ministry will review the matter with the director-general.”

However, Litzman added bluntly that if the hospitals did not cooperate and shorten the wait for MRI exams, he would “not hesitate to cancel their arrangements of choice.”

Such arrangements refer to agreements between the HMOs and hospitals to determine which medical center receives patients for which particular treatment.

Such a decision can exert major influence on an institution’s economic development.

Bottom line: if the hospitals don’t step up and cooperate, the health ministry is not likely to provide them with the support they need for further growth — at least, as long as Ya’acov Litzman remains health minister.

Hana Levi Julian

Dr. Orly Weinstein to Head Israel Hospitals Authority

Sunday, December 20th, 2015

Dr. Orly Weinstein has been chosen Health Minister Ya’acov Litzman to head the hospital authority that was formed out of the Israeli Health Ministry during the previous administration.

Weinstein’s responsibilities will include supervision over all general, geriatric and psychiatric medical centers that are owned and operated by the State of Israel.

Technically, the division to be administered by Weinstein is considered an authority separate and apart from the Health Ministry.

The change took place due to a reform approved by the cabinet during the tenure of the previous health minister, Yael German.

Weinstein is replacing Esther Dominissini, the first person to head the authority. Dominissini served as a former board chairperson of the Hadassah Medical Organization and other major agencies. She resigned after the most recent election.

Hana Levi Julian

Printed from: http://www.jewishpress.com/news/breaking-news/dr-orly-weinstein-to-head-israel-hospitals-authority/2015/12/20/

Scan this QR code to visit this page online: